{"i":{"9":{"name":"1 clodronate","spans":[{"i":"5503","f":"5513","txt":"clodronate"},{"i":"4978","f":"4988","txt":"clodronate"},{"i":"5186","f":"5196","txt":"clodronate"},{"i":"6101","f":"6111","txt":"clodronate"},{"i":"6771","f":"6781","txt":"clodronate"},{"i":"6975","f":"6985","txt":"clodronate"},{"i":"-1","f":"-1","txt":"Clodronate addition "}]},"16":{"name":"2 placebo","spans":[{"i":"5532","f":"5539","txt":"placebo"},{"i":"6244","f":"6251","txt":"placebo"},{"i":"6415","f":"6422","txt":"placebo"},{"i":"6579","f":"6586","txt":"placebo"},{"i":"6677","f":"6684","txt":"placebo"}]},"32":{"name":"3 Standard treatment","spans":[{"i":"-1","f":"18","txt":"Standard treatment "}]}},"o":{"23":{"name":"1 bone metastases at two","spans":[{"i":"5723","f":"5745","txt":"bone metastases at two"},{"i":"-1","f":"-1","txt":"Risk of bone metastases over 2 years"},{"i":"-1","f":"-1","txt":"Risk of bone metastases over 2 years (II/III disease)"}]},"25":{"name":"2 Survival status","spans":[{"i":"5805","f":"5820","txt":"Survival status"},{"i":"6739","f":"6752","txt":"Survival data"},{"i":"-1","f":"-1","txt":"Survival "},{"i":"-1","f":"-1","txt":"Survival (II/III disease)"}]},"27":{"name":"3 bone metastases in all patients over the 5 year","spans":[{"i":"6146","f":"6193","txt":"bone metastases in all patients over the 5 year"},{"i":"-1","f":"-1","txt":"Risk of bone metastases over 5 years"},{"i":"-1","f":"-1","txt":" Risk of bone metastases over 5 years (II/III disease)"}]},"30":{"name":"4 diarrhoea","spans":[{"i":"7028","f":"7037","txt":"diarrhoea"}]}}}